Mutations in the isocitrate dehydrogenase (IDH) genes are known to drive the development of low-grade gliomas, and indeed this molecular signature now distinguishes grade IV GBM from grade III anaplastic astrocytoma [8]. This evidence concerns the gene IDH1 and glioblastoma.